The ophthalmic medical lasers market size has grown strongly in recent years. It will grow from $1.33 billion in 2025 to $1.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing prevalence of age-related eye disorders, rising adoption of laser-based ophthalmic treatments, expansion of specialty eye clinics, improvements in laser safety standards, growing acceptance of outpatient eye procedures.
The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for advanced vision correction solutions, rising investments in ophthalmic laser innovation, expansion of laser-assisted surgeries in emerging markets, growing focus on personalized eye treatments, increasing adoption of AI-assisted laser guidance. Major trends in the forecast period include increasing adoption of minimally invasive laser procedures, rising use of femtosecond lasers in cataract surgery, growing precision in refractive error correction, expansion of multi-wavelength laser platforms, enhanced focus on faster patient recovery.
The growing elderly population is anticipated to drive the expansion of the ophthalmic medical lasers market in the coming years. The elderly population comprises individuals aged 65 years and above. The rise in the elderly population is attributed to increased life expectancy and improved overall survival, leading to a higher proportion of older adults within the population. Ophthalmic medical lasers are utilized for the elderly population to perform procedures such as cataract surgery, glaucoma treatment, age-related macular degeneration (AMD) management, diabetic retinopathy treatment, refractive lens exchange, and other ophthalmic interventions. For example, in October 2025, according to the World Health Organization, a Switzerland-based health organization, by 2030, one in six people globally (approximately 1.4 billion) will be aged 60 years or older. Additionally, by 2050, this figure is expected to double, reaching 2.1 billion older adults worldwide.
Major companies operating in the ophthalmic medical lasers market are concentrating on developing innovative advancements, including next-generation intraoperative radiotherapy (IORT) platforms, to improve precision, workflow efficiency, and patient safety during cancer treatment procedures. Next-generation IORT platforms are advanced systems that deliver targeted radiation directly to the tumor site during surgery, reducing exposure to surrounding healthy tissues while allowing more controlled and efficient treatment. For example, in April 2025, ZEISS, a Germany-based medical technology company, received FDA 510(k) clearance for its INTRABEAM 700 system, a robotic-assisted IORT solution developed to deliver highly focused radiation therapy for neuro-oncology and breast cancer surgeries. The platform incorporates enhanced imaging integration, optimized ergonomics, and increased control during radiation delivery, helping surgeons achieve more precise intraoperative treatment.
In July 2024, Alcon, a Switzerland-based healthcare company, acquired BELKIN Vision for an undisclosed amount. This acquisition aims to expand Alcon’s glaucoma portfolio and enhance global access to first-line laser treatment for glaucoma patients. BELKIN Vision, an Israel-based medical technology company, specializes in developing innovative laser treatments.
Major companies operating in the ophthalmic medical lasers market are Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, ThromboGenics NV.
North America was the largest region in the ophthalmic medical lasers market in 2025. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in the ophthalmic medical lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic medical lasers market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the ophthalmic medical lasers market by increasing costs of imported optical components, laser diodes, precision sensors, and advanced control electronics used in femtosecond, excimer, and ND:YAG laser systems. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-precision laser assemblies, while Asia-Pacific faces higher manufacturing and export-related costs. These tariffs are increasing capital expenditure for healthcare providers and slowing equipment replacement cycles. However, they are also encouraging localized assembly, regional supplier partnerships, and domestic production of ophthalmic laser components, supporting long-term supply chain resilience.
The ophthalmic medical lasers market research report is one of a series of new reports that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with a ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. This ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic medical lasers are used to treat a range of eye diseases, offering precise and minimally invasive treatment options. These lasers improve patient outcomes by reducing recovery times and enhancing the effectiveness of various ophthalmic procedures, such as surgeries for glaucoma, cataracts, and retinal conditions.
The primary products within the field of ophthalmic medical lasers include diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and other laser systems. Diode lasers are semiconductor devices that generate coherent radiation with the same frequency and phase, typically in either the visible or infrared spectrum, through the use of a p-n junction. These ophthalmic medical lasers find applications in a range of medical procedures, including refractive error correction, cataract removal, the treatment of diabetic retinopathy, glaucoma, age-related macular degeneration, and other ophthalmic conditions. These lasers are employed by various healthcare facilities, including hospitals, specialized ophthalmology clinics, and ambulatory surgery centers, to provide effective eye care and treatment.
The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ophthalmic medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for advanced vision correction solutions, rising investments in ophthalmic laser innovation, expansion of laser-assisted surgeries in emerging markets, growing focus on personalized eye treatments, increasing adoption of AI-assisted laser guidance. Major trends in the forecast period include increasing adoption of minimally invasive laser procedures, rising use of femtosecond lasers in cataract surgery, growing precision in refractive error correction, expansion of multi-wavelength laser platforms, enhanced focus on faster patient recovery.
The growing elderly population is anticipated to drive the expansion of the ophthalmic medical lasers market in the coming years. The elderly population comprises individuals aged 65 years and above. The rise in the elderly population is attributed to increased life expectancy and improved overall survival, leading to a higher proportion of older adults within the population. Ophthalmic medical lasers are utilized for the elderly population to perform procedures such as cataract surgery, glaucoma treatment, age-related macular degeneration (AMD) management, diabetic retinopathy treatment, refractive lens exchange, and other ophthalmic interventions. For example, in October 2025, according to the World Health Organization, a Switzerland-based health organization, by 2030, one in six people globally (approximately 1.4 billion) will be aged 60 years or older. Additionally, by 2050, this figure is expected to double, reaching 2.1 billion older adults worldwide.
Major companies operating in the ophthalmic medical lasers market are concentrating on developing innovative advancements, including next-generation intraoperative radiotherapy (IORT) platforms, to improve precision, workflow efficiency, and patient safety during cancer treatment procedures. Next-generation IORT platforms are advanced systems that deliver targeted radiation directly to the tumor site during surgery, reducing exposure to surrounding healthy tissues while allowing more controlled and efficient treatment. For example, in April 2025, ZEISS, a Germany-based medical technology company, received FDA 510(k) clearance for its INTRABEAM 700 system, a robotic-assisted IORT solution developed to deliver highly focused radiation therapy for neuro-oncology and breast cancer surgeries. The platform incorporates enhanced imaging integration, optimized ergonomics, and increased control during radiation delivery, helping surgeons achieve more precise intraoperative treatment.
In July 2024, Alcon, a Switzerland-based healthcare company, acquired BELKIN Vision for an undisclosed amount. This acquisition aims to expand Alcon’s glaucoma portfolio and enhance global access to first-line laser treatment for glaucoma patients. BELKIN Vision, an Israel-based medical technology company, specializes in developing innovative laser treatments.
Major companies operating in the ophthalmic medical lasers market are Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co. Ltd., Lumenis Ltd., Johnson & Johnson Surgical Vision Inc., Lumibird Medical, Quantel Inc., Coherent Inc., Ocular Instruments Inc., Ellex Medical Lasers Limited, LENSAR LLC, LIGHTMED Corporation, Menicon Co. Ltd., Novartis AG, Omeros Corporation, Oxurion NV, Regeneron Pharmaceuticals Inc., Roche Holding AG, Rohto Pharmaceutical Co. Ltd., Santen Pharmaceuticals, SCHWIND eye-tech-solutions GmbH & Co. KG, Staar Surgical Company, ThromboGenics NV.
North America was the largest region in the ophthalmic medical lasers market in 2025. Asia-Pacific was the second-largest region in the ophthalmic medical lasers market report. The regions covered in the ophthalmic medical lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic medical lasers market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the ophthalmic medical lasers market by increasing costs of imported optical components, laser diodes, precision sensors, and advanced control electronics used in femtosecond, excimer, and ND:YAG laser systems. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-precision laser assemblies, while Asia-Pacific faces higher manufacturing and export-related costs. These tariffs are increasing capital expenditure for healthcare providers and slowing equipment replacement cycles. However, they are also encouraging localized assembly, regional supplier partnerships, and domestic production of ophthalmic laser components, supporting long-term supply chain resilience.
The ophthalmic medical lasers market research report is one of a series of new reports that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with a ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. This ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ophthalmic medical lasers are used to treat a range of eye diseases, offering precise and minimally invasive treatment options. These lasers improve patient outcomes by reducing recovery times and enhancing the effectiveness of various ophthalmic procedures, such as surgeries for glaucoma, cataracts, and retinal conditions.
The primary products within the field of ophthalmic medical lasers include diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and other laser systems. Diode lasers are semiconductor devices that generate coherent radiation with the same frequency and phase, typically in either the visible or infrared spectrum, through the use of a p-n junction. These ophthalmic medical lasers find applications in a range of medical procedures, including refractive error correction, cataract removal, the treatment of diabetic retinopathy, glaucoma, age-related macular degeneration, and other ophthalmic conditions. These lasers are employed by various healthcare facilities, including hospitals, specialized ophthalmology clinics, and ambulatory surgery centers, to provide effective eye care and treatment.
The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ophthalmic Medical Lasers Market Characteristics
3. Ophthalmic Medical Lasers Market Supply Chain Analysis
4. Global Ophthalmic Medical Lasers Market Trends and Strategies
5. Ophthalmic Medical Lasers Market Analysis of End Use Industries
7. Global Ophthalmic Medical Lasers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ophthalmic Medical Lasers Total Addressable Market (TAM) Analysis for the Market
9. Ophthalmic Medical Lasers Market Segmentation
10. Ophthalmic Medical Lasers Market Regional and Country Analysis
11. Asia-Pacific Ophthalmic Medical Lasers Market
12. China Ophthalmic Medical Lasers Market
13. India Ophthalmic Medical Lasers Market
14. Japan Ophthalmic Medical Lasers Market
15. Australia Ophthalmic Medical Lasers Market
16. Indonesia Ophthalmic Medical Lasers Market
17. South Korea Ophthalmic Medical Lasers Market
18. Bangladesh Ophthalmic Medical Lasers Market
19. Thailand Ophthalmic Medical Lasers Market
20. Vietnam Ophthalmic Medical Lasers Market
21. Malaysia Ophthalmic Medical Lasers Market
22. Singapore Ophthalmic Medical Lasers Market
23. Philippines Ophthalmic Medical Lasers Market
24. Hong Kong Ophthalmic Medical Lasers Market
25. New Zealand Ophthalmic Medical Lasers Market
26. Taiwan Ophthalmic Medical Lasers Market
27. South East Asia Ophthalmic Medical Lasers Market
28. Western Europe Ophthalmic Medical Lasers Market
29. UK Ophthalmic Medical Lasers Market
30. Germany Ophthalmic Medical Lasers Market
31. France Ophthalmic Medical Lasers Market
32. Italy Ophthalmic Medical Lasers Market
33. Spain Ophthalmic Medical Lasers Market
34. Austria Ophthalmic Medical Lasers Market
35. Belgium Ophthalmic Medical Lasers Market
36. Denmark Ophthalmic Medical Lasers Market
37. Finland Ophthalmic Medical Lasers Market
38. Ireland Ophthalmic Medical Lasers Market
39. Netherlands Ophthalmic Medical Lasers Market
40. Norway Ophthalmic Medical Lasers Market
41. Portugal Ophthalmic Medical Lasers Market
42. Sweden Ophthalmic Medical Lasers Market
42. Switzerland Ophthalmic Medical Lasers Market
43. Eastern Europe Ophthalmic Medical Lasers Market
44. Russia Ophthalmic Medical Lasers Market
45. Czech Republic Ophthalmic Medical Lasers Market
46. Poland Ophthalmic Medical Lasers Market
47. Romania Ophthalmic Medical Lasers Market
48. Ukraine Ophthalmic Medical Lasers Market
49. North America Ophthalmic Medical Lasers Market
50. USA Ophthalmic Medical Lasers Market
51. Canada Ophthalmic Medical Lasers Market
52. Mexico Ophthalmic Medical Lasers Market
53. South America Ophthalmic Medical Lasers Market
54. Brazil Ophthalmic Medical Lasers Market
55. Chile Ophthalmic Medical Lasers Market
56. Argentina Ophthalmic Medical Lasers Market
57. Colombia Ophthalmic Medical Lasers Market
58. Peru Ophthalmic Medical Lasers Market
59. Middle East Ophthalmic Medical Lasers Market
60. Saudi Arabia Ophthalmic Medical Lasers Market
61. Israel Ophthalmic Medical Lasers Market
62. Iran Ophthalmic Medical Lasers Market
63. Turkey Ophthalmic Medical Lasers Market
64. United Arab Emirates Ophthalmic Medical Lasers Market
65. Africa Ophthalmic Medical Lasers Market
66. Egypt Ophthalmic Medical Lasers Market
67. Nigeria Ophthalmic Medical Lasers Market
68. South Africa Ophthalmic Medical Lasers Market
70. Ophthalmic Medical Lasers Market Competitive Landscape and Company Profiles
71. Ophthalmic Medical Lasers Market Other Major and Innovative Companies
74. Ophthalmic Medical Lasers Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Ophthalmic Medical Lasers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ophthalmic medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ophthalmic medical lasers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic medical lasers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Diode Lasers; Femtosecond Lasers; Excimer Lasers; Tissue Treatment Lasers; ND:Yag Lasers; Other Products2) By Application: Refractive Error Correction; Cataract Removal; Diabetic Retinopathy; Glaucoma; Age-Related Macular Degeneration; Other Applications
3) By End User: Hospitals; Specialty Clinics and Ambulatory Surgery Centres
Subsegments:
1) By Diode Lasers: Laser For Retinal Surgery; Laser For Cataract Surgery2) By Femtosecond Lasers: Laser For Cataract Surgery; Laser For LASIK Surgery
3) By Excimer Lasers: Laser For Refractive Surgeries (LASIK, PRK); Laser For Corneal Surgery
4) By Tissue Treatment Lasers: Lasers For Photodynamic Therapy; Laser For Tissue Treatment
5) By ND:YAG Lasers: Laser For Posterior Capsulotomy; Laser For Iridotomy
6) By Other Products: Laser For Glaucoma Treatment; Laser For Retinal Photocoagulation
Companies Mentioned: Alcon Laboratories Inc.; Abbott Medical Optics Inc.; Carl Zeiss Meditec AG; Bausch & Lomb Incorporated; Topcon Corporation; Ziemer Ophthalmic Systems AG; IRIDEX Corporation; NIDEK Co. Ltd.; Lumenis Ltd.; Johnson & Johnson Surgical Vision Inc.; Lumibird Medical; Quantel Inc.; Coherent Inc.; Ocular Instruments Inc.; Ellex Medical Lasers Limited; LENSAR LLC; LIGHTMED Corporation; Menicon Co. Ltd.; Novartis AG; Omeros Corporation; Oxurion NV; Regeneron Pharmaceuticals Inc.; Roche Holding AG; Rohto Pharmaceutical Co. Ltd.; Santen Pharmaceuticals; SCHWIND eye-tech-solutions GmbH & Co. KG; Staar Surgical Company; ThromboGenics NV
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ophthalmic Medical Lasers market report include:- Alcon Laboratories Inc.
- Abbott Medical Optics Inc.
- Carl Zeiss Meditec AG
- Bausch & Lomb Incorporated
- Topcon Corporation
- Ziemer Ophthalmic Systems AG
- IRIDEX Corporation
- NIDEK Co. Ltd.
- Lumenis Ltd.
- Johnson & Johnson Surgical Vision Inc.
- Lumibird Medical
- Quantel Inc.
- Coherent Inc.
- Ocular Instruments Inc.
- Ellex Medical Lasers Limited
- LENSAR LLC
- LIGHTMED Corporation
- Menicon Co. Ltd.
- Novartis AG
- Omeros Corporation
- Oxurion NV
- Regeneron Pharmaceuticals Inc.
- Roche Holding AG
- Rohto Pharmaceutical Co. Ltd.
- Santen Pharmaceuticals
- SCHWIND eye-tech-solutions GmbH & Co. KG
- Staar Surgical Company
- ThromboGenics NV
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.43 Billion |
| Forecasted Market Value ( USD | $ 1.89 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
